Clinical Trials Browser

Phase 2 × Non Squamous Non Small Cell Lung Cancer × toripalimab × Clear all

NCT05962021 2023-08-01

Neoadjuvant Toripalimab for Non-squamous NSCLC With EGFR Mutation

Phase 2 Not yet recruiting

Non Squamous Non Small Cell Lung Cancer